By considering the highlighted issues, in this study we defined PSA thresholds using a well calibrated risk prediction model for identifying or excluding advanced PCa, as an aid in personalized management of the diagnostic workup of redesigned screening programs. The gene discussed is KLK3; the disease is posterior cortical atrophy.